相关实验视频

Updated: Sep 15, 2025

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

通过p21激活激酶 (PAKs) 调节FGF1/PDE4D抗脂质聚变途径和脂肪细胞中的胰岛素抵抗

Judith Seigner¹, Johannes Krier¹, David Spähn²

¹Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich, Tübingen, Germany; Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital of Tübingen, Tübingen, Germany; German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.

Molecular metabolism

|July 14, 2025

概括

激活p21激活激酶 (PAKs) 调节纤维细胞生长因子1/化酶4D通路,影响脂肪分解和葡萄糖水平. 这一发现为2型糖尿病 (T2D) 和胰岛素抵抗 (IR) 提供了新的治疗点.

科学领域:

代谢过程中的代谢.
内分泌学在内分泌学.
细胞生物学细胞生物学

背景情况:

脂肪组织功能障碍,脂毒性和胰岛素抵抗 (IR) 是2型糖尿病 (T2D) 的核心原因.
纤维细胞生长因子1 (FGF1) /化酶4D (PDE4D) 途径通过抑制脂解来调节葡萄糖和脂质代谢.
对于其活性至关重要的PDE4D酸化的上游调节者以前是未知的.

研究的目的:

确定调节PDE4D酸化和FGF1/PDE4D通路的上游信号机制.
研究p21激活激酶 (PAKs) 在脂肪细胞功能,分化中的作用及其与T2D的联系.

主要方法:

使用小鼠脂肪细胞进行体外研究,以检查FGF1和PAK抑制对PDE4D酸化,cAMP水平和脂解的影响.
在小鼠和人类脂肪细胞培养物中慢性抑制PAKs,以评估脂质积累,脂肪原标记物表达和IR.

主要成果:

鉴定出PAKs是PDE4D酸化和FGF1-介导的脂解抑制的关键调节剂.
抑制PAKs干扰了FGF1的抗脂解功能,并通过PDE4D改变了cAMP调节.
慢性PAK抑制降低了脂肪,降低了脂肪生成标记物,并在脂肪细胞中诱导了IR.

结论:

帕克是脂肪细胞中FGF1/PDE4D抗脂质聚变途径的关键调节者.
帕克在脂肪生成和胰岛素抵抗的发展中发挥着重要作用.
帕克代表了管理T2D和相关代谢障碍的潜在治疗标.

关键词:

增脂生殖是一种增脂的过程.在FGF1/PDE4D中.胰岛素耐药性胰岛素耐药性是一种脂质溶解脂质溶解是一种 2 型糖尿病 2 型糖尿病通过p21激活的激酶.

更多相关视频

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

相关概念视频

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

cAMP-dependent Protein Kinase Pathways

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...